A Topical Treatment Optimisation Programme (TTOP) improves clinical outcome to calcipotriol/betamethasone gel in psoriasis: Results of the 64-week, multinational, randomized, phase IV study in 1790 patients (PSO-TOP)
Reich, K., Zschocke, I., Bachelez, H., de Jong, E.M.G.J., Gisondi, P., Puig, L., Warren, R.B., Ortland, C., Mrowietz, U.Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.15466
Date:
March, 2017
File:
PDF, 392 KB
english, 2017